122 related articles for article (PubMed ID: 20062096)
1. Development of severe sclerotic chronic GVHD during treatment with dasatinib.
Pulanic D; Cowen EW; Baird K; Bishop MR; Pavletic SZ
Bone Marrow Transplant; 2010 Sep; 45(9):1469-70. PubMed ID: 20062096
[No Abstract] [Full Text] [Related]
2. Dasatinib as salvage therapy for steroid refractory and imatinib resistant or intolerant sclerotic chronic graft-versus-host disease.
Sánchez-Ortega I; Servitje O; Arnan M; Ortí G; Peralta T; Manresa F; Duarte RF
Biol Blood Marrow Transplant; 2012 Feb; 18(2):318-23. PubMed ID: 22068151
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of dasatinib in a chronic myeloid leukemia patient with disease molecular relapse and chronic GVHD after haploidentical BMT: an immunomodulatory effect?
Breccia M; Cannella L; Stefanizzi C; Carotti A; Santopietro M; Alimena G
Bone Marrow Transplant; 2009 Sep; 44(5):331-2. PubMed ID: 19219075
[No Abstract] [Full Text] [Related]
4. Hemorrhagic colonic ulcers caused by dasatinib for chronic myelogenous leukemia.
Ono Y; Mori T; Kato J; Yamane A; Yajima T; Iwao Y; Hibi T; Okamoto S
Int J Hematol; 2010 Oct; 92(3):556-8. PubMed ID: 20824400
[No Abstract] [Full Text] [Related]
5. Dasatinib-induced pulmonary hypertension in chronic myelogenous leukaemia.
Yun S; Anwer F; Vincelette ND
BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24810451
[No Abstract] [Full Text] [Related]
6. Dasatinib-induced leukotrichia in a patient with chronic myelogenous leukemia.
Samimi S; Chu E; Seykora J; Loren A; Vittorio C; Rook A; Rosenbach M; Kim EJ
JAMA Dermatol; 2013 May; 149(5):637-9. PubMed ID: 23677113
[No Abstract] [Full Text] [Related]
7. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
8. Dasatinib in chronic myelogenous leukemia.
Kathula SK
N Engl J Med; 2006 Sep; 355(10):1062; author reply 1063-4. PubMed ID: 16957155
[No Abstract] [Full Text] [Related]
9. Viral infection or reactivation in patients during treatment with dasatinib: a call for screening?
Torres HA; Chemaly RF
Leuk Lymphoma; 2007 Dec; 48(12):2308-9. PubMed ID: 18067004
[No Abstract] [Full Text] [Related]
10. Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy.
Eskazan AE; Soysal T; Ongoren S; Gulturk E; Ferhanoglu B; Aydin Y
Haematologica; 2011 Mar; 96(3):e15; author reply e16-7. PubMed ID: 21357709
[No Abstract] [Full Text] [Related]
11. Double-edged sword of the new cancer therapeutics.
Force T
Circulation; 2012 May; 125(17):2057-8. PubMed ID: 22451582
[No Abstract] [Full Text] [Related]
12. Reversible lymph node follicular hyperplasia associated with dasatinib treatment of chronic myeloid leukemia in chronic phase.
Roux C; Nicolini FE; Rea D; Niault M; Mollica L; Berger F; Chassagne-Clément C; Tigaud I; Tulliez M; Giraudier S; Turhan A; Rousselot P; Legros L
Blood; 2013 Oct; 122(17):3082-4. PubMed ID: 24159167
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase.
Cortes J; Kim DW; Raffoux E; Martinelli G; Ritchie E; Roy L; Coutre S; Corm S; Hamerschlak N; Tang JL; Hochhaus A; Khoury HJ; Brümmendorf TH; Michallet M; Rege-Cambrin G; Gambacorti-Passerini C; Radich JP; Ernst T; Zhu C; Van Tornout JM; Talpaz M
Leukemia; 2008 Dec; 22(12):2176-83. PubMed ID: 18754032
[TBL] [Abstract][Full Text] [Related]
14. Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia.
Caocci G; Atzeni S; Orrù N; Azzena L; Martorana L; Littera R; Ledda A; La Nasa G
Leukemia; 2008 Nov; 22(11):2127-8. PubMed ID: 18463676
[No Abstract] [Full Text] [Related]
15. Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825).
García-Muñoz R; Galar A; Moreno C; Rodríguez-Otero P; Panizo-Morgado E; Ponz-Sarvisê M; Fernandez-Alonso M; Rubio M; Merino J; Cuesta B; Panizol C; Prosper F
Leuk Lymphoma; 2007 Dec; 48(12):2461-4. PubMed ID: 18067026
[No Abstract] [Full Text] [Related]
16. Reversible dasatinib-related pulmonary arterial hypertension diagnosed by noninvasive echocardiography.
Wang HC; Lee CS; Liu TC
Kaohsiung J Med Sci; 2015 Mar; 31(3):165-6. PubMed ID: 25744241
[No Abstract] [Full Text] [Related]
17. Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib.
Oweini H; Otrock ZK; Mahfouz RA; Bazarbachi A
Arch Gynecol Obstet; 2011 Jan; 283(1):133-4. PubMed ID: 20473616
[TBL] [Abstract][Full Text] [Related]
18. Acute colitis presenting with hematochezia in a patient with chronic myeloid leukemia during dasatinib therapy.
Eskazan AE; Hatemi İ; Öngören Aydın S; Ar MC; Soysal T
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():233. PubMed ID: 25910316
[No Abstract] [Full Text] [Related]
19. Severe dyspnoea in a patient with chronic myelogenous leukaemia on a tyrosine kinase inhibitor.
Ustun C; Randall N; Podgaetz E; Amin K; Dincer HE
Thorax; 2015 Jul; 70(7):701-4. PubMed ID: 25935168
[No Abstract] [Full Text] [Related]
20. Dasatinib-induced lupus.
Rea D; Bergeron A; Fieschi C; Bengoufa D; Oksenhendler E; Dombret H
Lancet; 2008 Aug; 372(9640):713-4. PubMed ID: 18761212
[No Abstract] [Full Text] [Related]
[Next] [New Search]
